GSK in talks to buy cancer biotech Nuvalent for more than $9bn

Deal would rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright, All Rights Reserved © UCWE Media